Brainsway Ltd (BWAY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Brainsway Ltd (BWAY) has a cash flow conversion efficiency ratio of 0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.17 Million) by net assets ($75.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Brainsway Ltd (BWAY) total market value for the company's overall valuation and market capitalisation.
Brainsway Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Brainsway Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Brainsway Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Brainsway Ltd ranked by their cash flow conversion efficiency. Explore Brainsway Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yingkou Jinchen Mach Co Ltd
SHG:603396
|
0.076x |
|
Jiangsu Hanvo Safety Product Co. Ltd.
SHE:300952
|
0.027x |
|
Korea New Network Co. Ltd
KQ:058400
|
0.023x |
|
Home Bancorp Inc
NASDAQ:HBCP
|
0.025x |
|
Meridian Mining UK Societas
TO:MNO
|
-0.105x |
|
AirAsia X Bhd
KLSE:5238
|
-4.848x |
|
Ennis Inc
NYSE:EBF
|
0.054x |
|
Beijing Sanlian Hope Shin-Gosen Technical Service Co Ltd
SHE:300384
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Brainsway Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Brainsway Ltd from 2012 to 2025. View BWAY live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $73.22 Million | $18.16 Million | 0.248x | +50.10% |
| 2024-12-31 | $62.31 Million | $10.30 Million | 0.165x | +435.19% |
| 2023-12-31 | $41.58 Million | $1.28 Million | 0.031x | +114.36% |
| 2022-12-31 | $45.40 Million | $-9.76 Million | -0.215x | -1494.17% |
| 2021-12-31 | $57.33 Million | $884.00K | 0.015x | +121.08% |
| 2020-12-31 | $19.63 Million | $-1.44 Million | -0.073x | +75.55% |
| 2019-12-31 | $24.22 Million | $-7.24 Million | -0.299x | +44.89% |
| 2018-12-31 | $6.95 Million | $-3.77 Million | -0.543x | -99.13% |
| 2017-12-31 | $12.72 Million | $-3.47 Million | -0.273x | -16.72% |
| 2016-12-31 | $10.29 Million | $-2.40 Million | -0.233x | +33.85% |
| 2015-12-31 | $12.89 Million | $-4.55 Million | -0.353x | -44.97% |
| 2014-12-31 | $15.58 Million | $-3.79 Million | -0.244x | -50.97% |
| 2013-12-31 | $14.65 Million | $-2.36 Million | -0.161x | +77.22% |
| 2012-12-31 | $7.92 Million | $-5.60 Million | -0.708x | -- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more